S. 2658

119th CONGRESS 1st Session

To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

IN THE SENATE OF THE UNITED STATES · August 1, 2025 · Sponsor: Ms. Hassan · Committee: Committee on Health, Education, Labor, and Pensions

Table of contents

• S. 2658
  • 274. Non-disclosure defense to infringement of drug patent.

274. Non-disclosure defense to infringement of drug patent.